Dr. John Charlson and his patient Megan joined us to help educate viewers on Synovial Sarcoma, early diagnosis and how to find a treatment center. Synovial sarcoma, a life-threatening cancer, ...

KUTV — July is Sarcoma Awareness Month, a time to raise understanding about rare cancers like synovial sarcoma—a life-threatening soft tissue cancer that often appears as a painful lump near the knee, ...

SAN ANTONIO — July is Sarcoma Awareness Month, a time to bring attention to many deadly types of cancer. One of those is called synovial sarcoma, which typically presents itself as a painful lump ...

Cell therapies first reached patients as treatments for blood cancers. Adaptimmune Therapeutics’ work in this therapeutic modality has culminated in an FDA nod in synovial sarcoma, a regulatory ...

A collaborative research team, led by scientists at VCU Massey Comprehensive Cancer Center and Huntsman Cancer Institute at ...

Patients with advanced synovial sarcoma may have a new therapy option if the novel drug, afami-cel, is approved by the FDA after the priority review. The Food and Drug Administration (FDA) has ...

The probability of overall survival after 1, 5, and 10 years was predicted by a nomogram model, which found that worse Surveillance, Epidemiology, and End Results (SEER) stage was associated with ...

The US Food and Drug Administration has approved afamitresgene autoleucel (afami-cel) (Tecelra, Adaptimmune LLC) to treat advanced synovial sarcoma. Afami-cel — the first engineered cell therapy for a ...

Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization ...

Use of histologic and immunologic factors in sarcoma to predict response rates to immunotherapy. A phase II study of an oncolytic herpes simplex virus 2 and an anti-PD-1 antibody in patients with ...